Nidda Will Squeeze Out Remaining Stada Shares
Minority Shareholders Account For Just Over 2% Of German Firm’s Total
Stada’s owner has revealed plans to squeeze out the German firm’s remaining minority shareholders.
You may also be interested in...
Nidda Healthcare, the investment vehicle controlled by Bain Capital and Cinven, has decided on a share price for the final squeeze-out of Stada’s remaining minority shareholders.
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.
Stada has outlined its growth plans for markets in the Asia-Pacific region. While it aims to become a top player in Vietnam’s generics market through a local entity for which it has just received formal clearance, the German firm is also partnering with other with companies in China, Hong Kong, the Philippines and Thailand.